Pharmaceutical Chemistry
Avinash Rangaraju

Name of the Faculty: Mr. Avinash Rangaraju
Designation: Assistant Professor
Qualification: M. Pharm.
Teaching Experience (Years): 16 years
Email:avinash.rangaraju@bcp.edu.in
Specialization / Area of Expertise:Synthesis of small molecules for antitubercular treatment, NIRF Nodal Officer and as Faculty Advisor in ACS-BCP student chapter.
Professional Overview :
Mr. Avinash Rangaraju serves as an Assistant Professor in the Department of Pharmaceutical Chemistry at Bombay College of Pharmacy. With a strong foundation in pharmaceutical sciences and a commitment to academic excellence, he contributes to teaching, research, and institutional development.
Academic Appointments
- Avinash plays an active role in curriculum development, aligning syllabi with Choice-Based Credit System (CBCS) and emerging trends in pharmaceutical sciences.
- He contributes to examination committees, internal quality audits, and NAAC documentation, ensuring compliance with the University of Mumbai and AICTE norms.
- His leadership extends to organizing faculty development programs (FDPs) and skill enhancement workshops, fostering a culture of continuous learning
Research Interests and Contributions
- Primary focus on synthetic medicinal chemistry, including design and evaluation of antibacterial, antitubercular, antioxidant, and wound-healing agents.
- Synthesis, characterization and biological screening of heterocyclic compounds of therapeutic Interest.
Research Interests and Contributions
- Google Scholar:
- Total citations: 25
- h-index: 3
- i10-index: 1.
- Notable Publications:
- Sustainable dressings for wound healing (Biotechnology for Sustainable Materials, 2025) - 10 citations.
- Isatin derivative studies (Medicinal Chemistry Research, 2012) - 8 citations.
- Novel indole-dione antimycobacterial agents (Int. J. Adv. Pharm. Biol. Chem, 2013) - 7 citations.
- Recent antioxidant Schiff-base series (EPRA IJRD, 2025).
Research Grants and Collaborations
- Publishes collaboratively, indicating active research networks with colleagues (e.g., K. Murali, P. Ambre).
Societal Impact and Community Engagement
- Through ACS-BCP student chapter, organizes knowledge-sharing events (e.g., seminars on drug discovery).
- Encourages student involvement in science outreach and interactive discussions.
Innovation, Patents, and Digital Health Initiatives
- No patent filings or formal digital-health initiatives found in public domains.
- Demonstrates innovation in academic research—designing bioactive compounds and proposing synthetic methods—but no registered IP.
Mentorship, Awards, and Recognitions
- Mentors ACS-BCP Student Chapter activities and guides students in scholarly events.
- No formal awards or recognitions recorded in available online profiles.
Professional Memberships and Editorial Roles
- Active with American Chemical Society, serving as Faculty Advisor for its BCP chapter.
- No listings found for editorial board roles or other society memberships.
Recent Publications: (Best Five in last five years)
| Sr. No. | Publication Title | Author(s) | Journal / Conference Name | Year of Publication | Volume / Issue / Page Nos | Type (Journal, Conference, Book Chapter, Patent, etc.) |
|---|---|---|---|---|---|---|
| 1 | Sustainable Dressings for Wound Healing | Munishwar Nath Gupta, Premlata Ambre and Avinash Rangaraju | Biotechnology for Sustainable Materials | Jan-25 | Vol. 21 | Journal |
| 2 | A comprehensive review on Management of Hashimoto's disease using Dietary Approaches comparative Analysis Saracitinib, Nilotinib and dasatinib based on their safety, efficacy and tolerability in treating Alzheimer's disease. | Hasan Ali Javed Badshah*, Mohamed Sami Najmuddin Ravuthar, Alfaz Pathan and Avinash Rangaraju | World Journal of Pharmaceutical Research | Nov-24 | Journal | |
| 3 | comparaitive Analysis Saracitinib, Nilotinib and dasatinib based on their safety, efficacy and tolerability in treating Alzheimers disease. | Dhairya Arun Bheda, Pranjali Dinesh Pawar, Avinash Rangaraju, Abhishek Rathod | World Journal of Pharmaceutical Research | Oct-24 | Journal |
